Guest guest Posted February 5, 2008 Report Share Posted February 5, 2008 http://www.bloomberg.com/apps/news? pid=20601085 & sid=aFqrZJ.lkXzQ & refer=europe Feb. 5 (Bloomberg) -- The childhood vaccination that combines measles, mumps and rubella doesn't raise the risk of developing autism, according to the largest study to examine a possible link between the inoculations and the brain disorder. Researchers found no significant differences in immune response between a group of autistic children, a group of non- autistic children with special educational needs, and children who were developing normally. The study was published in the Archives of Disease in Childhood today. Some parents began avoiding the vaccine after a 1998 study of 12 youngsters published in the Lancet medical journal linked the combined Measles-Mumps-Rubella shot to autism. While 10 of 12 authors have since retracted that study's findings, the share of U.K. children being vaccinated fell to 80 percent in 2004 from 92 percent in 1996. ``We've really gone for every possible control group and we found no difference,'' Gillian Baird, a professor and children's neurologist at Guy's Hospital in London and author of the report, said in a phone interview. ``I hope that this will give parents confidence that they can have their children vaccinated with MMR.'' Baird and her team examined 250 children born in 1990 and 1991 in southeast England who had been given the MMR vaccine. Autism is an umbrella term covering several developmental and communication disorders that affect as many as 12 of every 1,000 children, the study said. The ``significant'' rise in reported cases of autism over the past 10 years can likely be attributed to broader diagnostic criteria and improved detection methods, Baird said. ``This doesn't rule out environmental contributions to the manifestation of autism, but there is nothing very obvious that people are pointing to,'' Baird said. MMR vaccines include MMR II by U.S. drugmaker Merck & Co., Priorix by London-based GlaxoKline Plc, and Trimovax by Sanofi-Aventis SA's Sanofi-Pasteur unit. Glaxo spokesman Joss Mathieson declined to comment, while spokespeople at Sanofi- Pasteur and Merck did not immediately return calls seeking comment. To contact the reporter on this story: Trista Kelley in London at tkelley2@... Last Updated: February 5, 2008 08:40 EST Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 6, 2008 Report Share Posted February 6, 2008 They failed to mentioned other studies where investigators have found, for example, live measles virus in the cerebral spinal fluid in children who become autistic after MMR vaccination. Antibodies to measles virus are elevated in children with autism but not in normal kids, suggesting that virus-induced autoimmunity may play a causal role. > > > http://www.bloomberg.com/apps/news? > pid=20601085 & sid=aFqrZJ.lkXzQ & refer=europe > > Feb. 5 (Bloomberg) -- The childhood vaccination that combines > measles, mumps and rubella doesn't raise the risk of developing > autism, according to the largest study to examine a possible link > between the inoculations and the brain disorder. > > Researchers found no significant differences in immune response > between a group of autistic children, a group of non- autistic > children with special educational needs, and children who were > developing normally. The study was published in the Archives of > Disease in Childhood today. > > Some parents began avoiding the vaccine after a 1998 study of 12 > youngsters published in the Lancet medical journal linked the > combined Measles-Mumps-Rubella shot to autism. While 10 of 12 authors > have since retracted that study's findings, the share of U.K. > children being vaccinated fell to 80 percent in 2004 from 92 percent > in 1996. > > ``We've really gone for every possible control group and we found no > difference,'' Gillian Baird, a professor and children's neurologist > at Guy's Hospital in London and author of the report, said in a phone > interview. ``I hope that this will give parents confidence that they > can have their children vaccinated with MMR.'' > > Baird and her team examined 250 children born in 1990 and 1991 in > southeast England who had been given the MMR vaccine. > > Autism is an umbrella term covering several developmental and > communication disorders that affect as many as 12 of every 1,000 > children, the study said. The ``significant'' rise in reported cases > of autism over the past 10 years can likely be attributed to broader > diagnostic criteria and improved detection methods, Baird said. > > ``This doesn't rule out environmental contributions to the > manifestation of autism, but there is nothing very obvious that > people are pointing to,'' Baird said. > > MMR vaccines include MMR II by U.S. drugmaker Merck & Co., Priorix by > London-based GlaxoKline Plc, and Trimovax by Sanofi-Aventis SA's > Sanofi-Pasteur unit. Glaxo spokesman Joss Mathieson declined to > comment, while spokespeople at Sanofi- Pasteur and Merck did not > immediately return calls seeking comment. > > To contact the reporter on this story: Trista Kelley in London at > tkelley2@... > > Last Updated: February 5, 2008 08:40 EST > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.